Chemistry, manufacturing and controls (CMC) are an integral step in creating an effective biological product — and a crucial element of an effective biologics regulatory submission. CMC activities ...
All stages of the drug development lifecycle require the proper adherence to regulatory chemistry, manufacturing and control (CMC) requirements. Join this two-day workshop for an overview of CMC ...
The market opportunity lies in offering specialized training and consultancy services to pharmaceutical companies for navigating complex CMC regulatory requirements for biological drugs, ensuring ...
This webinar explores an integrated approach to mAb development that embeds manufacturability, scalability, lifecycle ...
At a conference early next year, biologics manufacturers will be encouraged to develop a chemistry, manufacturing, and controls (CMC) management strategy for their reference material early in ...
Dr. Olga Paley, Director of Bioprocess Development at Takeda, will discuss “Advancing Takeda’s Bioprocessing Platforms in Support of Clinical and Commercial Drug Supply” about the Chemistry, ...
Toronto, Ontario and Haifa, Israel--(Newsfile Corp. - February 10, 2026) - NurExone Biologic Inc. (NRX:CA) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results